Is Chemours (CC) Pricing Reflect Recent Volatility And Discounted Cash Flow Outlook

Simply Wall St.

Yesterday

If you are wondering whether Chemours is offering good value at its current price, or if the recent moves are signaling something else about the stock, this article focuses squarely on what the ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2614806903"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2614806903\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2614806903?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/2022000-choice2-main-header/1585186835382","is_english":true,"pubTime":"2026-02-26 09:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2614806903","market":"sg","top_or_hot":-1,"title":"Is Chemours (CC) Pricing Reflect Recent Volatility And Discounted Cash Flow Outlook","media":"Simply Wall St.","content":"<div>\n<p>If you are wondering whether Chemours is offering good value at its current price, or if the recent moves are signaling something else about the stock, this article focuses squarely on what the ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/materials/nyse-cc/chemours/news/is-chemours-cc-pricing-reflect-recent-volatility-and-discoun\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Chemours (CC) Pricing Reflect Recent Volatility And Discounted Cash Flow Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Chemours (CC) Pricing Reflect Recent Volatility And Discounted Cash Flow Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-26 09:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/materials/nyse-cc/chemours/news/is-chemours-cc-pricing-reflect-recent-volatility-and-discoun><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you are wondering whether Chemours is offering good value at its current price, or if the recent moves are signaling something else about the stock, this article focuses squarely on what the ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/materials/nyse-cc/chemours/news/is-chemours-cc-pricing-reflect-recent-volatility-and-discoun\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DCF","symbol_name":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","start_time":0,"source_url":"https://simplywall.st/stocks/us/materials/nyse-cc/chemours/news/is-chemours-cc-pricing-reflect-recent-volatility-and-discoun","article_id":"2614806903","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/2022000-choice2-main-header/1585186835382"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-cc/chemours/news/is-chemours-cc-pricing-reflect-recent-volatility-and-discoun","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2614806903","pubTimestamp":1772069946,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"If you are wondering whether Chemours is offering good value at its current price, or if the recent moves are signaling something else about the stock, this article focuses squarely on what the numbers say about value.\nChemours' share price closed at US$18.02, with returns of 14.1% over the last 30 days, 47.1% year to date and 16.9% over the past year, while the 7-day return of a 14.8% decline and longer term 3-year and 5-year returns of 42.4% and a 16.4% decline show a mixed picture for...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","BK4098":"多种化学制品","CC":"Chemours Company"},"translate_title":"科慕(CC)的定价是否反映了近期的波动性和贴现现金流前景","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DCF":1,"CC":1.5},"content_text":"If you are wondering whether Chemours is offering good value at its current price, or if the recent moves are signaling something else about the stock, this article focuses squarely on what the numbers say about value. Chemours' share price closed at US$18.02, with returns of 14.1% over the last 30 days, 47.1% year to date and 16.9% over the past year, while the 7-day return of a 14.8% decline and longer term 3-year and 5-year returns of 42.4% and a 16.4% decline show a mixed picture for investors thinking about risk and reward. Recent news coverage around Chemours has centered on its position in the chemicals sector, changes in investor sentiment toward cyclical materials companies, and how the market is treating businesses with exposure to industrial demand. Together, these factors help frame why the stock has moved the way it has in the short and medium term and provide useful context before you weigh up whether the current price looks attractive compared to different estimates of value. Chemours currently has a valuation score of 5/6, based on a framework where 1 point is added for each of 6 checks the company appears undervalued on. Next, we will walk through those valuation approaches before finishing with a different way of thinking about value that many investors overlook.  Chemours delivered 16.9% returns over the last year. See how this stacks up to the rest of the Chemicals industry. AdvertisementApproach 1: Chemours Discounted Cash Flow (DCF) Analysis A Discounted Cash Flow model takes estimates of the cash a company might generate in the future and discounts those cash flows back to today, to arrive at an estimate of what the business could be worth now. For Chemours, the model used is a 2 Stage Free Cash Flow to Equity approach. The company’s last twelve months free cash flow is reported as a loss of $46 million, so the valuation leans heavily on future estimates rather than recent cash generation. Analyst inputs and extrapolated projections suggest free cash flow rising to $421.5 million in 2028. A series of annual forecasts is provided out to 2035, all expressed in dollars and discounted back to today within the model. Putting those projected cash flows together, the DCF model arrives at an estimated intrinsic value of about $49.48 per share. Compared with the recent share price of $18.02, this implies an intrinsic discount of roughly 63.6%, which indicates that Chemours is trading at a substantial discount to this cash flow based estimate. Result: UNDERVALUED Our Discounted Cash Flow (DCF) analysis suggests Chemours is undervalued by 63.6%. Track this in your watchlist or portfolio, or discover 53 more high quality undervalued stocks. CC Discounted Cash Flow as at Feb 2026 Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Chemours. Approach 2: Chemours Price vs Sales For companies where earnings can be volatile, the P/S ratio is often a useful way to look at value, because it compares the share price to the revenue the business is generating rather than to short term profits. Investors usually expect higher growth and lower risk companies to trade on a higher P/S multiple, while slower growth or higher risk names tend to sit on lower P/S ratios. Chemours currently trades on a P/S of 0.47x, compared with the Chemicals industry average of 1.19x and a peer average of 1.14x. Simply Wall St also provides a proprietary “Fair Ratio” of 0.88x, which is an estimate of what a normal P/S might look like for Chemours given factors such as its earnings growth profile, industry, profit margins, market cap and specific risks. This Fair Ratio can be more informative than a simple comparison with peers or the broad industry, because it adjusts for Chemours’ own characteristics rather than applying a one size fits all yardstick. With the current P/S of 0.47x sitting meaningfully below the 0.88x Fair Ratio, Chemours appears inexpensive on this sales based measure. Result: UNDERVALUED NYSE:CC P/S Ratio as at Feb 2026 P/S ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 21 top founder-led companies. Upgrade Your Decision Making: Choose your Chemours Narrative Earlier we mentioned that there is an even better way to understand valuation. On Simply Wall St that means using Narratives, where you write a short story about Chemours that reflects your view on its future revenue, earnings and margins. You then link that story to a set of forecasts and a Fair Value, and compare that Fair Value with the current share price. This all happens in an easy tool on the Community page that updates automatically when new news or earnings arrive. One investor might build a more optimistic Chemours Narrative around a Fair Value of about US$21.00, while another might take a more cautious stance closer to US$13.00. Seeing those different stories side by side helps you decide which assumptions you personally find more reasonable before you choose your own Narrative. For Chemours, however, we will make it really easy for you with previews of two leading Chemours Narratives: Each one blends the current valuation work with a different view on future earnings, PFAS legal risk and how much investors might be willing to pay for those earnings. Your job is simply to decide which assumptions feel closer to how you see the company. 🐂 Chemours Bull Case Fair value in this bullish narrative: US$21.00 Current price vs that fair value: about 14.2% below the narrative fair value Revenue growth used in the model: 4.76% per year  Assumes Opteon refrigerants, advanced materials and specialty fluoropolymers keep gaining traction, with segment margins and free cash flow improving as the mix shifts toward higher value products. Builds in cleaner visibility on PFAS and other environmental liabilities, with past settlements and cash generation giving Chemours more room to invest, rebalance the portfolio or pursue deals. Uses a higher future P/E multiple and improving profit margins to reach a US$21.00 fair value, so you would need to be comfortable that earnings, margins and the balance sheet can support that valuation over time.  🐻 Chemours Bear Case Fair value in this bearish narrative: US$13.00 Current price vs that fair value: about 38.6% above the narrative fair value Revenue growth used in the model: 4.52% per year  Assumes PFAS class actions and broader environmental regulation keep legal and remediation costs elevated, which could pressure future net margins and free cash flow even if revenue continues to grow. Emphasizes Chemours’ reliance on a relatively narrow product set, where tighter ESG standards, customer preferences for alternatives and shifts in trade protection could hit pricing power and volume. Applies a lower future P/E multiple of around 5.38x and keeps fair value at US$13.00, so you would need to believe that ongoing legal risk and cost pressure justify a discount to current pricing.  If you want to go beyond previews and weigh these earnings, risk and valuation assumptions in detail, the full bull and bear write ups are a useful way to pressure test your own view before you commit fresh capital or decide to sit on the sidelines. Curious how numbers become stories that shape markets? Explore Community Narratives Do you think there's more to the story for Chemours? Head over to our Community to see what others are saying! NYSE:CC 1-Year Stock Price Chart  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}